Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction

Circulation

Volumn 99, Issue 21, 1999, Pages 2717-2719

  Terashima, Masahiro ^a   Akita, Hozuka ^a   Kanazawa, Kenji ^a   Inoue, Nobutaka ^a   Yamada, Shinichiro ^a   Ito, Keiichi ^a   Matsuda, Yasuaki ^a   Takai, Eiji ^a   Iwai, Chikao ^a   Kurogane, Hiroyuki ^b   Yoshida, Yutaka ^b   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Himeji Cardiovascular Center   (Japan)

Author keywords

Metalloproteinases; Myocardial infarction; Plaque; Risk factors

Indexed keywords

MATRIX METALLOPROTEINASE; STROMELYSIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; EXTRACELLULAR MATRIX; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

EID: 0033151560     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.21.2717     Document Type: Article

References (10)

1. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
2. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
3. Shah PK, Falk E, Badimon JJ, Ortiz AF, Mailhac A, Levy GV, Fallon JT, Regnstrom J, Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Circulation. 1995;92:1565-1569.
4. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
5. Woessner JJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
6. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J. 1995;73: 209-215.
7. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 1996;271:13055-13060.
8. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
9. Buttice G, Quinones S, Kurkinen M. The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin gene. Nucleic Acids Res. 1991;19:3723-3731.
10. Quinones S, Saus J, Otani Y, Harris JED, Kurkinen M. Transcriptional regulation of human stromelysin. J Biol Chem. 1989;264:8339-8344.